HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Esophageal cancer is a malignancy that occurs in the esophagus, the muscular tube that connects the throat to the stomach. This type of cancer is relatively uncommon but can be aggressive and challenging to treat. The two main types of esophageal cancer are adenocarcinoma and squamous cell carcinoma, each with distinct risk factors and characteristics.
Adenocarcinoma usually originates in the glandular cells lining the lower part of the esophagus. It is often associated with gastroesophageal reflux disease (GERD) and Barrett's esophagus, a condition where the normal esophageal lining is replaced with tissue similar to that found in the intestine. On the other hand, squamous cell carcinoma typically develops in the upper and middle parts of the esophagus and is often linked to tobacco and excessive alcohol consumption.
Symptoms of esophageal cancer may include difficulty swallowing, unintentional weight loss, chest pain or discomfort, and persistent coughing. Early detection is challenging, and esophageal cancer is often diagnosed at an advanced stage. Treatment options depend on the stage of the cancer but may include surgery, chemotherapy, radiation therapy, and targeted therapies.
Preventive measures include lifestyle changes such as quitting smoking, moderating alcohol intake, and managing acid reflux. Regular medical check-ups and screenings for individuals with risk factors can contribute to early detection and improved outcomes. Ongoing research aims to uncover more effective treatment strategies and better understand the molecular mechanisms underlying esophageal cancer, offering hope for advancements in its management.
